Journal of Cardiovascular Disease Research
STUDY ON EVALUATION OF TYPE OF THYROID LESIONS ON FNAC USING BETHESDA SYSTEM
Dr. D. Nagendra Prasad Naik, Dr. N.V.H. Rajesh Krishna, Dr. Byrappagari Spandana, Dr. Suneetha Kona
JCDR. 2023: 3456-3462
Abstract
Background: Fine needle aspiration cytology [FNAC] is a valuable screening tool available for distinguishing between benign and malignant thyroid swelling. Thyroid lesions subjected to FNAC are categorized under Bethesda system to ensure standardization amongst reporting. Methods and Material: This prospective study was done over a period of 2 years, i.e., April 2021 to March 2023 in the Department of Pathology, Sri Venkateswara Medical College, Tirupati. A total of 600 patients with thyroid lesions attending the OPD’s of Surgery, Medicine and ENT were included in this study. Results: Benign lesions were the most commonly found lesions. In present study, females are most commonly involved. Among follow-up malignancy prevalence was increased amongst those with Category V and Category 6. Conclusions: FNAC is a cost-effective system for screening malignant lesions. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) helps in the interpretations of cytological findings of thyroid using FNAC.
» PDF